Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0.26) Estimate, Sales $1.990M Miss $16.263M Estimate
Cellectis SA Sponsored ADR -1.91% Pre
Cellectis SA Sponsored ADR CLLS | 1.80 1.80 | -1.91% 0.00% Pre |
Cellectis (NASDAQ:
CLLS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.26) by 146.15 percent. The company reported quarterly sales of $1.990 million which missed the analyst consensus estimate of $16.263 million by 87.76 percent. This is a 88.51 percent decrease over sales of $17.322 million the same period last year.